The Diagnosis of Chronic Pancreatitis

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2013 by Haukeland University Hospital
Sponsor:
Collaborator:
University of Bergen
Information provided by (Responsible Party):
Georg Gjorgji Dimcevski, Haukeland University Hospital
ClinicalTrials.gov Identifier:
NCT01059669
First received: January 29, 2010
Last updated: July 7, 2013
Last verified: July 2013

January 29, 2010
July 7, 2013
August 2009
August 2014   (final data collection date for primary outcome measure)
  • Development of pancreatic insufficiency [ Time Frame: 3 years ] [ Designated as safety issue: No ]
  • Peak enzyme Concentration IE [ Time Frame: one year ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01059669 on ClinicalTrials.gov Archive Site
  • development of diabetes [ Time Frame: 3 year ] [ Designated as safety issue: No ]
  • Development of pain [ Time Frame: 3 years ] [ Designated as safety issue: No ]
  • weight loss [ Time Frame: 3 years ] [ Designated as safety issue: No ]
  • peak amylase [ Time Frame: one year ] [ Designated as safety issue: No ]
  • development of diabetes [ Time Frame: 3 year ] [ Designated as safety issue: No ]
  • Development of pain [ Time Frame: 3 years ] [ Designated as safety issue: No ]
  • weight loss [ Time Frame: 3 years ] [ Designated as safety issue: No ]
lipase peak IE [ Time Frame: one year ] [ Designated as safety issue: No ]
Not Provided
 
The Diagnosis of Chronic Pancreatitis
A Multimodal Approach to Diagnose Patients With Chronic Pancreatitis

To develop a new standardized multimodal diagnostic approach to CP considering fat in faeces, imaging and functional testing; the combination of tests has to be easy to practice, should take as little time as possible and discomfort for the patient has to be minimized

To evaluate the reliability and feasibility of these novel methods in healthy volunteers; AND

To compare findings in known severe CP patients and different stages of pancreatic insufficiency in patients with CP.

Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

Pankreatic juice Duodenal tissue Blood

Probability Sample

Patient with suspected chronic pancreatitis age 18-67 years

Chronic Pancreatitis
Other: diagnostic test
  • Patients
    Patients with suspected Chronic Pancreatitis
    Intervention: Other: diagnostic test
  • Control group
    Healthy controls
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
30
August 2015
August 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • The patients will be included from the Department of Medicine at Haukeland University Hospital in Norway. The Marseille-Rome/Cambridge diagnostic criteria will be used.The symptoms should be unrelated to other systemic diseases.

Exclusion Criteria:

  • Personality disturbances and alcohol consumption 24 hours prior to the study. Any other diseases and drugs associated with malabsorption; pregnancy or lactating women; heart disease or allergy against MR or ultrasound contrast agents.
Both
18 Years to 67 Years
Yes
Contact: Georg Dimcevski, M.D 55972903 dgeo@helse-bergen.no
Contact: Gilja Odd Helge, Professor 55975000 odhg@helse-bergen.no
Norway
 
NCT01059669
REK nr 241.08
No
Georg Gjorgji Dimcevski, Haukeland University Hospital
Haukeland University Hospital
University of Bergen
Principal Investigator: Georg Dimcevski, PhD Haukeland University Hospital
Haukeland University Hospital
July 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP